Medanta delivered a robust FY26 with 20% revenue growth, driven by rapid ramp-up in Noida and maturity in Lucknow/Patna. Management is balancing high-intensity expansion with maintained 24-25% EBITDA margins.
Atlanta Electricals delivered a defining FY26 with robust revenue growth and significant margin expansion driven by a richer 220KV product mix and new capacity at the Vadod facility.
Persistent delivered $1,654.4M revenue in FY26 (+17.4% YoY) with an AI-led strategy. Q4 FY26 marked the 24th sequential quarter of growth with EBIT margin at 16.3%.
Artemis Medicare delivered strong FY26 results with consolidated revenue of ₹1,081 Cr, up 15.4% YoY. Strategy focuses on expanding bed capacity and high-end quaternary care.
CARE Ratings delivered strong FY26 performance with consolidated revenue growing 18% to ₹473cr and PAT up 24% to ₹174cr. The company is pivoting towards AI-driven analytics and expanding its global rating footprint.
Vishal Mega Mart delivered strong FY26 results with a focus on private label dominance and aggressive tier-2/3 expansion despite rising inflationary pressures.
Advanced Enzyme reported its highest-ever quarterly and annual revenue for FY26. Management focused on expanding R&D, human healthcare flagship growth, and navigating global supply chain disruptions.
United Spirits (Diageo India) reported 7.6% Total NSV growth and 8.6% P&A NSV growth for FY26, driven by premiumization and portfolio re-shaping under 'Three Indias' strategy.
Solar Industries delivered stellar FY26 performance with 30% revenue growth and 35% PAT growth. Management issued strong FY27 guidance targeting ₹14,000cr revenue, driven by defense and international markets.
Cholamandalam MS General Insurance (subsidiary) reported Q4 FY26 GDPI of ₹2,048cr and PBT of ₹454cr, focusing on motor car segments and non-crop business expansion.
Alembic Pharma reported Q4FY26 revenue of INR 18.48 Bn, up 4% YoY, and PAT of INR 2.03 Bn, up 29% YoY. The company launched its first branded product, Pivya, in the US.